Copenhagen, Denmark

Jurgen Beyer

This inventor holds 1 USPTO granted patent. Top assignee: Poseidon Pharmaceuticals A/s. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jurgen Beyer. Retrieved from https://idiyas.com/inventor/jurgen-beyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jurgen Beyer: Innovator in Ion Channel Modulation

Introduction

Jurgen Beyer is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of ion channel modulating agents. His work focuses on a specific class of chemical compounds that have shown promise in modulating various ion channels.

Latest Patents

Jurgen Beyer holds a patent for ion channel modulating agents. This invention relates to a particular class of chemical compounds that are effective as modulators of SK Ca, IK Ca, and BK Ca channels. The patent outlines the use of these agents in the manufacture of medicaments, therapeutic methods, and pharmaceutical compositions. These modulating agents are particularly useful for treating or alleviating diseases and conditions associated with the SK/IK/BK channels.

Career Highlights

Beyer is associated with Poseidon Pharmaceuticals A/S, where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas, particularly those related to ion channel dysfunction.

Collaborations

Some of his notable coworkers include Bo Skaaning Jensen and Dorte Strobaek, who contribute to the collaborative efforts at Poseidon Pharmaceuticals A/S.

Conclusion

Jurgen Beyer's innovative work in ion channel modulation represents a significant advancement in pharmacological research. His contributions have the potential to lead to new therapeutic options for patients suffering from related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…